424B3FORM 424B3
Jun 16, 2026Final prospectus0001062993-26-003216
All companies
Trade Conexeu Sciences IncConexeu Sciences to Ring Nasdaq Bell on June 10, 2026 Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
Conexeu Sciences Inc
CNXUPublic
PublicUnited States(NASDAQ Capital)Best valuation $325.92M1 market
Public listing
Listed· NASDAQ Capital· Listing market: United StatesListing date
May 21, 2026
Offer price
Not available
Shares offered
9,481,123
Offering proceeds
Not available
Sources: lifecycle-news, sec-harvest, nasdaq
IPO Calendar · NASDAQIPO
CNXUPrice
$12.18
24h
-8.28%
Valuation
$325.92M
24h volume
$877.41K
Type
IPO
Trade Conexeu Sciences IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
About Conexeu Sciences Inc
Conexeu Sciences Inc is an operating company with a business profile centered on its products, services, customers, and execution strategy.
What the company does
- Operates with a business profile defined by its products, services, customers, and operating execution.
- Its durable fundamentals depend on demand for its products or services, margin structure, competitive position, management execution, and capital discipline.
- Primary company filings and official materials are the best source for detailed information about revenue drivers, risk factors, and operating strategy.
Business profile
Conexeu Sciences Inc should be evaluated through its durable business model: what it sells, who it serves, how it generates revenue, and how efficiently it can scale.
SEC IPO filings
Final prospectusEDGAR filings resolved from CNXU / CIK 0002066836.
424B3FORM 424B3
May 15, 2026Final prospectus0001062993-26-002716
424B3FORM 424B3
May 15, 2026Final prospectus0001062993-26-002661
May 11, 2026Effective9999999995-26-001569
424B4FORM 424B4
May 11, 2026Final prospectus0001062993-26-002473
May 11, 2026Exchange registration0001354457-26-000435
8-A12BFORM 8-A12B
May 11, 2026Exchange registration0001062993-26-002453
S-1/AFORM S-1/A
Apr 17, 2026Amended0001062993-26-002041
S-1/AFORM S-1/A
Apr 10, 2026Amended0001062993-26-001914
S-1/AFORM S-1/A
Apr 6, 2026Amended0001062993-26-001871
S-1/AFORM S-1/A
Mar 26, 2026Amended0001062993-26-001640
S-1/AFORM S-1/A
Mar 5, 2026Amended0001062993-26-001297
Latest Conexeu Sciences Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
NasdaqJun 3, 2026IPO filing
Conexeu Sciences (Nasdaq: CNXU) announced it will ring the Nasdaq Closing Bell on June 10, 2026, in celebration of its recent public listing and the commencement of trading under the ticker CNXU.
Conexeu Sciences, Inc. (IR)Jun 3, 2026IPO context
Company investor-relations update tied to its Nasdaq debut celebration (IPO/listing context).
NasdaqMay 21, 2026IPO filing
Direct listing/trading start announcement for Conexeu Sciences Inc. on Nasdaq under CNXU.
Conexeu Sciences Inc IPO — frequently asked questions
- When did Conexeu Sciences Inc go public?
- Conexeu Sciences Inc completed its IPO on May 21, 2026 on NASDAQ Capital under the ticker CNXU and now trades publicly.
- Can I buy Conexeu Sciences Inc stock?
- Yes — Conexeu Sciences Inc is publicly traded on NASDAQ Capital as CNXU. You can follow its live price, valuation and post-IPO performance above.
- What is Conexeu Sciences Inc's valuation?
- Conexeu Sciences Inc's most recent valuation tracked here is $325.92M, derived from live market prices.